These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 28547960)

  • 1. Histological perspective on the effects of tumor-associated macrophages in the tumor microenvironment surrounding papillary thyroid carcinoma.
    Can NY; Ayturk S; Celik M; Sezer YA; Ozyilmaz F; Tastekin E; Sut N; Ustun F; Bulbul BY; Puyan FO; Guldiken S
    Pol J Pathol; 2016; 67(4):332-344. PubMed ID: 28547960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion.
    Chang WC; Chen JY; Lee CH; Yang AH
    Thyroid; 2013 Jun; 23(6):720-6. PubMed ID: 23186064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of the Impact of Hashimoto Thyroiditis on Papillary Thyroid Carcinoma Progression: Relationship with the Tumor Immune Microenvironment.
    Sulaieva O; Chernenko O; Selesnov O; Nechay O; Maievskyi O; Falalyeyeva T; Kobyliak N; Tsyryuk O; Penchuk Y; Shapochka D
    Endocrinol Metab (Seoul); 2020 Jun; 35(2):443-455. PubMed ID: 32615729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Cell Confrontation in the Papillary Thyroid Carcinoma Microenvironment.
    Xie Z; Li X; He Y; Wu S; Wang S; Sun J; He Y; Lun Y; Zhang J
    Front Endocrinol (Lausanne); 2020; 11():570604. PubMed ID: 33193087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Escape Mechanism is Impaired in the Microenvironment of Thyroid Lymph Node Metastasis.
    Cunha LL; Nonogaki S; Soares FA; Vassallo J; Ward LS
    Endocr Pathol; 2017 Dec; 28(4):369-372. PubMed ID: 28730569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL5 expression is associated with active signals of macrophages in the microenvironment of papillary thyroid carcinoma.
    Le TN; Le MK; Dang MX; Kondo T
    Pathol Res Pract; 2024 Sep; 261():155474. PubMed ID: 39067172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphological difference in adult thyroid papillary carcinoma between Japan and Ukraine.
    Ito M; Bogdanova T; Zurnadzhy L; Saenko V; Rogounovitch T; Mitsutake N; Kondo H; Maeda S; Nakashima M; Tronko M; Yamashita S
    Endocr J; 2014; 61(12):1221-8. PubMed ID: 25242260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune Landscape of Thyroid Cancers: New Insights.
    Menicali E; Guzzetti M; Morelli S; Moretti S; Puxeddu E
    Front Endocrinol (Lausanne); 2020; 11():637826. PubMed ID: 33986723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EWSR1 rearrangement is a frequent event in papillary thyroid carcinoma and in carcinoma of the thyroid with Ewing family tumor elements (CEFTE).
    Oliveira G; Polónia A; Cameselle-Teijeiro JM; Leitão D; Sapia S; Sobrinho-Simões M; Eloy C
    Virchows Arch; 2017 May; 470(5):517-525. PubMed ID: 28236059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological Evidence of Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Can N; Tastekin E; Ozyilmaz F; Sezer YA; Guldiken S; Sut N; Sarikas N; Oz Puyan F; Guler B; Ayturk S; Celik M
    Endocr Pathol; 2015 Sep; 26(3):218-28. PubMed ID: 26209182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.
    Fang W; Ye L; Shen L; Cai J; Huang F; Wei Q; Fei X; Chen X; Guan H; Wang W; Li X; Ning G
    Carcinogenesis; 2014 Aug; 35(8):1780-7. PubMed ID: 24608042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential role of M2 TAMs around lymphatic vessels during lymphatic invasion in papillary thyroid carcinoma.
    Kabasawa T; Ohe R; Aung NY; Urano Y; Kitaoka T; Tamazawa N; Utsunomiya A; Yamakawa M
    Sci Rep; 2021 Jan; 11(1):1150. PubMed ID: 33441903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Clinicopathologic and Radiographic Findings Between TT-UMP, Classical, and Non-Encapsulated Follicular Variants of Papillary Thyroid Carcinomas.
    Baser H; Topaloglu O; Tam AA; Alkan A; Kilicarslan A; Ersoy R; Cakir B
    Endocr Pathol; 2016 Sep; 27(3):233-42. PubMed ID: 27256097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In situ evidence of neoplastic cell phagocytosis by macrophages in papillary thyroid cancer.
    Fiumara A; Belfiore A; Russo G; Salomone E; Santonocito GM; Ippolito O; Vigneri R; Gangemi P
    J Clin Endocrinol Metab; 1997 May; 82(5):1615-20. PubMed ID: 9141559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies.
    Muzza M; Degl'Innocenti D; Colombo C; Perrino M; Ravasi E; Rossi S; Cirello V; Beck-Peccoz P; Borrello MG; Fugazzola L
    Clin Endocrinol (Oxf); 2010 May; 72(5):702-8. PubMed ID: 20447069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative ultrasonographic features of papillary thyroid carcinoma predict biological behavior.
    Nam SY; Shin JH; Han BK; Ko EY; Ko ES; Hahn SY; Chung JH
    J Clin Endocrinol Metab; 2013 Apr; 98(4):1476-82. PubMed ID: 23463652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 Endometrial Cancer is Associated With a High Density of Tumor-Associated Macrophages in the Stromal Compartment.
    Kelly MG; Francisco AM; Cimic A; Wofford A; Fitzgerald NC; Yu J; Taylor RN
    Reprod Sci; 2015 Aug; 22(8):948-53. PubMed ID: 25701837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lymphocytic thyroiditis on histology correlates with serum thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: impact on detection of serum thyroglobulin.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2380-7. PubMed ID: 22539585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thyroglobulin autoantibodies in patients with papillary thyroid carcinoma: comparison of different assays and evaluation of causes of discrepancies.
    Latrofa F; Ricci D; Montanelli L; Rocchi R; Piaggi P; Sisti E; Grasso L; Basolo F; Ugolini C; Pinchera A; Vitti P
    J Clin Endocrinol Metab; 2012 Nov; 97(11):3974-82. PubMed ID: 22948755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FoxP3 expression in papillary thyroid carcinoma: a possible resistance biomarker to iodine 131 treatment.
    Ugolini C; Elisei R; Proietti A; Pelliccioni S; Lupi C; Borrelli N; Viola D; Leocata P; Vitti P; Miccoli P; Toniolo A; Basolo F
    Thyroid; 2014 Feb; 24(2):339-46. PubMed ID: 23915122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.